| 
Oral Opportunistic
Infections:
hairy
leukoplakia/ oropharyngeal candidias/ oral warts
Posaconazole
for the Treatment of Candidiasis in People with HIV - 2/09/07
Posaconazole
versus Fluconazole for the Treatment of Oropharyngeal Candidiasis in HIV
Patients - 3/21/06
Continuous
versus Episodic Use of Fluconazole for Candidiasis in HIV Patients on HAART
- 10/19/05
Decline
in Esophageal Candidiasis and Use of Antimycotics in European HIV Patients
-
7/06/05
Oral
Candidiasis During HAART Treatment Suggests Immune Failure 3/23/05
Oral
Opportunistic Infections in HIV Positive Individuals
12/06/04
Oral Opportunistic Infections in HIV Positive
Individuals: Role of Mucosal Immunity 09/27/04
Anidulafungin May Be Useful Treatment Alternative
for Esophageal Candidiasis, Especially for Patients Intolerant to Other
Drugs 09/03/04
Study Results Suggest Micafungin Is a Valuable
New Treatment Option for Esophageal Candidiasis in HIV Patients 09/03/04
Oral Candidiasis and Seborrheic Dermatitis
in HIV-infected Patients on HAART 03/15/04
Guidelines for Treatment of Candidiasis,
a Common and Often Dangerous Fungal OI in People with AIDS 01/07/04
Trial of High-dose Fluconazole (Diflucan)
Versus Fluconazole plus Amphotericin B as Therapy for Candidemia -
06/09/03
Vulvovaginal Candidiasis Occurs among HIV-infected
Women More Frequently and with Greater Persistence, but Not Greater Severity
-
04/02/03
High Incidence of Vulvovaginal Candidiasis in
HIV-infected Women -
03/31/03
CD8+ T Cells May Combat Oral Candidiasis,
but Activity Lessened in HIV Patients -
03/12/03
Fluconazole-Resistant Candida Effectively Treated
with Cancidas (Caspofungin) -
11/11/02
Caspofungin Equivalent to Fluconazole for Esophageal
Candidiasis -
11/01/02
Candida Resistance to Azole Antifungals Decreasing
in HAART Era -
09/23/02
Caspofungin Helpful Against Esophageal Candidiasis
in HIV Patients -
09/13/02
Cyclodextrin Itraconazole Effective in HIV-Positive
Children with Oropharyngeal Candidiasis -
08/16/02
Esophageal Candidiasis Persists in HIV
Positive Children Who Respond Poorly to HAART -
06/12/02
Candida-Specific Antibodies Fail to Explain HIV-Related
Oropharyngeal Candidiasis -
05/31/02
PI-Containing
HAART Regimens Have Direct Effect Against Oral Candidiasis
- 01/28/02
|
